OR WAIT null SECS
January 02, 2014
Janssen's donation program will improve access to the company's approved HIV medicines for children and adolescents in sub-Saharan Africa.
The Bristol-Myers Squibb Foundation is awarding 10 grants to fund programs for veterans and their families.
December 30, 2013
Baxter International recalls dextrose injection and four sodium chloride injections.
December 19, 2013
Encap will collaborate with Lipocine to manufacture Lipcine's oral testosterone product, LPCN 1021, for Phase III clinical trials.
Bind Therapeutics amends its development and commercialization collaboration agreement with Amgen.
Everett Laboratories acquires Quinnova Pharmaceuticals, a specialty pharmaceutical company.
Merck and GlaxoSmithKline begin clinical trial of pazopanib for the treatment of advanced renal-cell carcinoma.
Siemens enters agreement with Pfizer to commercialize diagnostic tests for therapeutic products across Pfizer's pipeline.
CMC Biologics and OnoSynergy form an agreement from cell-line development.
Pfizer appoints management changes to take effect in 2014.